ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
manuscript11_chemrxiv.pdf (1.8 MB)

Blood Retention and Antigenicity of Polycarboxybetaine-Modified Liposomes

preprint
submitted on 03.04.2020, 02:13 and posted on 06.04.2020, 07:07 by Taka-aki Ryujin, Taro Shimizu, Ryo Miyahara, Rena Shimazui, Takuma Yoshikawa, Akihiro Kishimura, Takeshi Mori, Tatsuhiro Ishida, Yoshiki Katayama
Zwitterionic polycarboxybetaines (PCBs) have gained attention as alternative stealth polymers whose
liposomal formulation and protein conjugates were reported not to elicit anti-polymer antibodies. Here, we
studied the blood retention and antigenicity of liposomes modified with PCBs focusing on their chemical
structures and doses. We compared PCBs with either 1 or 3 (PCB1 or PCB3) spacer carbons between the
carboxylate and ammonium groups. PCB3-modified liposomes had a short blood retention, whereas PCB1-
modified liposomes demonstrated extended blood retention that was somewhat superior to PEGylated liposome.
This confirmed the excellent non-fouling nature of PCB1 reported previously. Interestingly, PCB1-liposome as
well as PCB3-liposome elicited specific IgMs toward each PCB. The dose-dependent production of specific
IgMs to PCB-liposomes was similar to that of PEGylated liposome, i.e., high doses of PCB-liposomes reduced
the production of specific IgMs, termed immunological tolerance. These results indicate the importance of
investigating the effect of dose to clarify the existence of antigenicity of stealth polymers

History

Email Address of Submitting Author

mori.takeshi.880@m.kyushu-u.ac.jp

Institution

Kyushu University

Country

Japan

ORCID For Submitting Author

0000-0002-1821-5427

Declaration of Conflict of Interest

The Authors declare that there is no conflict of interest.

Exports